Diot Christa M, Thomas Robyn L, Raess Liliane, Wrightson James G, Condliffe Elizabeth G
Alberta Children's Hospital, Calgary, Canada.
Hotchkiss Brain Institute, Calgary, Canada.
Disabil Rehabil Assist Technol. 2023 Jul;18(5):497-501. doi: 10.1080/17483107.2021.1878296. Epub 2021 Feb 4.
With few treatment options available for non-ambulatory children with cerebral palsy (CP), a robotic lower extremity gait trainer may provide a non-invasive addition to conventional treatment options. This case study investigates the usage and impact of robotic lower extremity gait trainer use in a participant with CP over the initial 3 months of use.
This prospective case study involves a 7-year old female (GMFCS V) with CP (registered clinical trial: NCT04251390). The participant used a Trexo Home robotic gait trainer (Trexo) in the community with assessments occurring in the home and school. Trexo usage and bowel movements (BMs) were tracked daily. Postural control and lower extremity range of motion (ROM) and spasticity were evaluated prior to Trexo use and weekly to biweekly thereafter.
The participant used the device an average of 46 min/week, over 3.3 d/week. BM frequency increased from 0.4/d at baseline, to 1.2 (±0.5)/d during Trexo use. There were no diffuse systematic changes in postural stability, ROM or muscle spasticity, but specifically head control and spasticity in the knee flexors had improvements.
Data and anecdotal reports suggest that regular use of the Trexo Home robotic gait trainer has positive outcomes on frequency and quality of BMs, and may improve head control, and knee flexor spasticity. Larger controlled studies are needed to evaluate the impacts of Trexo use in children with CP.Implications for RehabilitationNon-ambulatory children with CP can use and may experience benefits from using a robot-assisted gait trainer (RAGT).Constipation, aspects of balance and focal spasticity may improve.
由于针对非行走型脑瘫(CP)儿童的治疗选择有限,机器人下肢步态训练器可为传统治疗方法提供一种非侵入性补充。本案例研究调查了一名CP患儿在使用机器人下肢步态训练器的最初3个月中的使用情况及其影响。
这项前瞻性案例研究涉及一名7岁女性CP患儿(GMFCS V级,注册临床试验:NCT04251390)。该参与者在社区中使用Trexo Home机器人步态训练器(Trexo),并在家庭和学校进行评估。每天跟踪Trexo的使用情况和排便情况。在使用Trexo之前以及之后每周至每两周评估一次姿势控制、下肢活动范围(ROM)和痉挛情况。
该参与者平均每周使用该设备46分钟,每周使用3.3天。排便频率从基线时的每天0.4次增加到使用Trexo期间的每天1.2(±0.5)次。姿势稳定性、ROM或肌肉痉挛没有全身性的系统性变化,但头部控制和膝部屈肌的痉挛情况有改善。
数据和轶事报告表明,定期使用Trexo Home机器人步态训练器对排便频率和质量有积极影响,并且可能改善头部控制和膝部屈肌痉挛。需要更大规模的对照研究来评估Trexo对CP患儿的影响。康复意义非行走型CP患儿可以使用机器人辅助步态训练器(RAGT),并可能从中受益。便秘、平衡方面和局部痉挛情况可能会改善。